RU-1205

From WikiMD.com - Food, Medicine & Wellness Encyclopedia

Synthetic nonsteroidal estrogen


RU-1205
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


RU-1205 is a synthetic, nonsteroidal estrogen of the stilbestrol group that was developed in the 1960s. It is structurally related to diethylstilbestrol (DES), a well-known synthetic estrogen.

Chemical structure and properties[edit | edit source]

RU-1205 is a member of the stilbestrol family, characterized by its nonsteroidal structure. The compound is defined by its chemical formula, which includes a phenolic hydroxyl group and a dimethylaminoethoxy side chain. This structure is similar to that of other synthetic estrogens, which allows it to bind to estrogen receptors in the body.

Chemical structure of RU-1205

Pharmacology[edit | edit source]

As an estrogen, RU-1205 interacts with estrogen receptors, which are part of the nuclear receptor family of intracellular receptors. These receptors, when activated by binding to an estrogen, can influence the expression of specific genes, leading to the physiological effects associated with estrogenic activity. The precise binding affinity and activity of RU-1205 compared to other estrogens like DES or natural estrogens such as estradiol are subjects of pharmacological interest.

Potential applications[edit | edit source]

RU-1205, like other synthetic estrogens, was initially investigated for its potential use in hormone replacement therapy and other estrogen-related treatments. However, due to the adverse effects associated with synthetic estrogens, particularly those related to DES, the clinical use of RU-1205 has been limited.

Safety and side effects[edit | edit source]

The safety profile of RU-1205 has not been extensively documented in the literature. However, it is known that synthetic estrogens can have significant side effects, including an increased risk of thromboembolism, breast cancer, and endometrial cancer. These risks have led to a decline in the use of nonsteroidal synthetic estrogens in clinical practice.

Related compounds[edit | edit source]

RU-1205 is related to other synthetic estrogens such as diethylstilbestrol and hexestrol. These compounds share a similar mechanism of action but differ in their pharmacokinetic properties and side effect profiles.

Related pages[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD